PCNU治疗复发性髓母细胞瘤和室管膜瘤——一项儿童肿瘤学组（POG）的研究
PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study.
作者信息
Ragab A H, Burger P, Badnitsky S, Krischer J, Van Eys J
出版信息
J Neurooncol. 1986;3(4):341-2. doi: 10.1007/BF00165583.
PMID:3958779
Abstract
Seventeen children with recurrent medulloblastoma and ependymoma received PCNU (100 mg/m2) in a Phase II trial. Response was evaluated by CAT scan. There were no responses. Administration of PCNU was associated with significant thrombocytopenia.
摘要
17名复发性髓母细胞瘤和室管膜瘤患儿在一项II期试验中接受了PCNU（100mg/m²）治疗。通过计算机断层扫描（CAT）评估反应。未出现反应。PCNU的使用与显著的血小板减少症相关。
Zotero 插件